Related Experiment Video
Updated: Jan 22, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
New Medications in the Treatment of Acute Migraine
1Prescribe Right, LLC, Wildwood, MO, USA.
Abstract:
Migraine is a common disorder affecting 12% of the US population. Use of triptans results in migraine pain relief within 2 hours in 16% to 51% of patients. However, due to their vasoconstrictive properties, triptans are contraindicated in patients with cardiovascular disease, peripheral vascular disease, cerebrovascular disease, and uncontrolled hypertension because of the potential for ischemia. This article will review 2 new classes of drugs being developed for the treatment of acute migraine without vasoconstrictive effects.
Related Concept Videos
Inhaled Medications
Heart Failure V: Medical Management
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management

